Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02979 |
| Species: | Mus musculus |
| Position : | chr2:91067374-91069374 |
| Year: | 2014 |
| Title: | The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Leukemia |
| PMID: | 25185713 |
| Tissue: | blood / hematopoietic system |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Bone Marrow Cell,Leukemic Stem Cell,Hematopoietic Stem Cell,416B |
| Experiment Type: | TF-binding/chromatin assay; Chromatin interaction assay; In vivo functional validation; Disease-associated enhancer analysis |
| Low Throughput Method: | ChIP-qPCR/ChIP; 3C; Transgenic/LacZ assay |
| Target gene : | Spi1 |
| TF name : | Runx2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Runx2 | AndrogenReceptor | netpath | 167 |
| Runx2 | FGF signaling pathway | pid | 55 |
| Runx2 | Leptin | netpath | 98 |
| Runx2 | Notch-mediated HES/HEY network | pid | 48 |
| Runx2 | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| Runx2 | Regulation of retinoblastoma protein | pid | 67 |
| Runx2 | TGF_beta_Receptor | netpath | 220 |
| Runx2 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | reactome | 29 |
| Runx2 | Hs_MAPK_Signaling_Pathway_WP382_79951 | wikipathways | 58 |
| Runx2 | Hs_Endochondral_Ossification_WP474_87977 | wikipathways | 43 |
| Runx2 | Hs_Role_of_Osx_and_miRNAs_in_tooth_development_WP3971_91525 | wikipathways | 9 |
| Runx2 | Hs_Bone_Morphogenic_Protein_(BMP)_Signalling_and_Regulation_WP1425_86082 | wikipathways | 6 |
| Runx2 | Hs_Focal_Adhesion-PI3K-Akt-mTOR-signaling_pathway_WP3932_91101 | wikipathways | 8 |